Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial

被引：2
|
作者：
Pfeiler, G.
Koenigsberg, R.
Mlineritsch, B.
Stoger, H.
Singer, C. F.
Poestlberger, S.
Steger, G.
Seifert, M.
Dubsky, P. C.
Jakesz, R.
Samonigg, H.
Bjelic-Radisic, V.
Greil, R.
Marth, C.
Fesl, C.
Gnant, M.
机构：
[1] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria
[2] Inst Translat Res Vienna CEADDP, Vienna, Austria
[3] Paracelsus Univ Salzburg, Salzburg, Austria
[4] Med Univ Klin Graz, Graz, Austria
[5] Med Univ Vienna, Gen Hosp, Vienna, Austria
[6] Hosp Sisters Mercy, Linz, Austria
[7] Med Univ Vienna, Vienna, Austria
[8] Med Univ Vienna, Dept Surg, Vienna, Austria
[9] Med Univ, Dept Internal Med, Graz, Austria
[10] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria
[11] Univ Hosp Salzburg, Dept Med 3, Salzburg, Austria
[12] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria
[13] Austrian Breast & Colorectal Canc Study Grp, Vienna, Austria
[14] Med Univ Vienna, Dept Surg, Ctr Comprehens Canc, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
514
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Effect of body mass index on the efficacy of adjuvant tamoxifen in premenopausal patients with hormone receptor-positive breast cancer
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Ozdemir, Nuriye Y.
    Zengin, Nurullah
    Yazici, Ozan
    Sever, Ali R.
    Altundag, Kadri
    JOURNAL OF BUON, 2016, 21 (01): : 27 - 34
  • [32] Effect of body mass index (BMI) on outcomes after surgical resection and adjuvant therapy for pancreatic cancer patients
    Khawaja, M. R.
    Zyromski, N.
    Yu, M.
    Cardenes, H. R.
    Schmidt, C. M.
    Sandusky, G.
    Howard, T. J.
    Chiorean, E. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [33] The efficacy of neoadjuvant endocrine therapy during the waiting period for surgery in premenopausal hormone receptor positive breast cancer
    Maeda, Y.
    Sato, A.
    Matsumoto, A.
    Ikeda, T.
    Jinno, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1407 - S1407
  • [34] Body mass index (BMI), change in BMI, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    Sue, Laura Y.
    Genkinger, Jeanine M.
    Schairer, Catherine
    Ziegler, Regina G.
    CANCER RESEARCH, 2010, 70
  • [35] ADDITION OF ZOLEDRONIC ACID (ZOL) TO ADJUVANT ENDOCRINE THERAPY IMPROVES DISEASE-FREE (DFS) AND RECURRENCE-FREE SURVIVAL (RFS) IN PREMENOPAUSAL WOMEN WITH HORMONE-RESPONSIVE EARLY BREAST CANCER (HREBC): MULTIVARIATE ANALYSES OF THE AUSTRIAN BREAST AND COLORECTAL CANCER STUDY GROUP 12 (ABCSG-12) TRIAL
    Gnant, M.
    Mlineritsch, B.
    Schippinger, W.
    Luschin-Ebengreuth, G.
    Poestlberger, S.
    Menzel, C.
    Jakesz, R.
    Kubista, E.
    Marth, C.
    Greil, R.
    ANNALS OF ONCOLOGY, 2009, 20 : 30 - 30
  • [36] BODY MASS INDEX (BMI) AND AMENORRHEA IN PREMENOPAUSAL BREAST CANCER PATIENTS (PBC) TREATED WITH ADJUVANT ANTRACYCLINE AND CYCLOPHOSPAMIDE CHEMOTHERAPY (CT)
    Zaccarelli, E.
    Rossi, L.
    Tomao, F.
    Giordani, E.
    Verrico, M.
    Strudel, M.
    Perrone-Congedi, F.
    Papa, A.
    Caruso, D.
    Capalbo, C.
    Rinaldi, G.
    Bianchi, L.
    Lo Russo, G.
    Spinelli, G. P.
    Prete, A.
    Stati, V.
    Evangelista, S.
    Tomao, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 : 18 - 19
  • [37] Long-Term Follow-Up in ABCSG-12: Significantly Improved Overall Survival with Adjuvant Zoledronic Acid in Premenopausal Patients with Endocrine-Receptor Positive Early Breast Cancer.
    Gnant, M.
    Mlineritsch, B.
    Luschin-Ebengreuth, G.
    Stoeger, H.
    Dubsky, P.
    Jakesz, R.
    Singer, C.
    Eidtmann, H.
    Fesi, C.
    Eiermann, W.
    Marth, C.
    Greil, R.
    CANCER RESEARCH, 2011, 71
  • [38] Efficacy and tolerability of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer: a retrospective analysis
    Qin, T.
    Yuan, Z. Y.
    Peng, R. J.
    Zeng, Y. D.
    Shi, Y. X.
    Teng, X. Y.
    Liu, D. G.
    Bai, B.
    Wang, S. S.
    CURRENT ONCOLOGY, 2013, 20 (04) : 196 - 204
  • [39] Efficacy of adjuvant tamoxifen in hormone receptor-positive premenopausal breast cancer patients according to the body mass index
    Altundag, Kadri
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Babacan, Taner
    Ozisik, Yavuz
    CANCER RESEARCH, 2015, 75
  • [40] Baseline body mass index (BMI) and the development of prostate cancer (CAP) in the medical therapy of prostatic symptoms (MTOPS) trial
    Andriole, GL
    Noble, WD
    Lucia, MS
    Kusek, JW
    Roehrborn, CG
    JOURNAL OF UROLOGY, 2005, 173 (04): : 71 - 71
12345